Quarterly Activities/Appendix 4C Cash Flow Report

Jul 30, 2026 at 8:59 PM EDT · Issued by Neurotech International Ltd. via ASX

Filed with ASX · Jul 30, 2026 at 8:59 PM EDT

On 6ix: 6ix.com/news/quarterly-activitiesappendix-4c-cash-flow-report-814

ASX Announcement Neurotech International Ltd Suite 102 / Level 1, 55 Collins Street, Melbourne, VIC 3000 T : 03 9498 3132 E: info@neurotechinternational.com W: neurotechinternational.com ABN: 73 610 205 402 ASX: NTI 1 of 4 31 July 2026 Quarterly Activities Report ...

View Attachment

6ix hasn’t read this filing yet.

Neurotech International Ltd. on 6ix

Earlier from Neurotech International

Trading HaltJul 30
NTI164 Phase II/III Autism Data Accepted for PublicationJul 29
Neurotech secures $3.15 million R&D tax incentive loanJul 14
US FDA clears IND for NTI164Jul 13
NTI secures Notices of Allowance for US patent applicationsJul 1

Later from Neurotech International

Proposed issue of securities - NTIAug 3
Receipt of Binding Commitments for $4.5m PlacementAug 3
Application for quotation of securities - NTIAug 11
Secondary Trading NoticeAug 11
Becoming a substantial holderAug 12

All Neurotech International news releases

Follow Neurotech International into a list and get an email when it puts out news.

Follow Neurotech International